Log in

LON:NUCNucleus Financial Group Share Price, Forecast & News

GBX 132.50
0.00 (0.00 %)
(As of 05/25/2020 06:53 AM ET)
Add
Compare
Today's Range
133
Now: GBX 132.50
133
50-Day Range
122.50
MA: GBX 137.42
145
52-Week Range
100
Now: GBX 132.50
225
Volume1,080 shs
Average VolumeN/A
Market Capitalization£101.33 million
P/E Ratio16.99
Dividend Yield2.59%
BetaN/A
Nucleus Financial Group Plc operates an online wrap platform for the financial services industry. The company's wrap platform offers adviser users custody, trading, payment, reporting, fee-handling, research, and integration services across an open architecture universe, including cash, OEICs, unit trusts, offshore funds, structured products and listed securities, and investment trusts through a range of tax wrappers. It also operates Narrate, a portfolio reporting tool. The company was founded in 2006 and is headquartered in Edinburgh, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars


Industry, Sector and Symbol

Industry Asset Management
Sub-IndustryN/A
SectorFinancial Services
CUSIPN/A
CIKN/A
Phone44 1312 269 535

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£51.52 million
Cash FlowGBX 25.22 per share
Book ValueGBX 26 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£101.33 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NUC News and Ratings via Email

Sign-up to receive the latest news and ratings for NUC and its competitors with MarketBeat's FREE daily newsletter.

Nucleus Financial Group (LON:NUC) Frequently Asked Questions

How has Nucleus Financial Group's stock been impacted by COVID-19 (Coronavirus)?

Nucleus Financial Group's stock was trading at GBX 143.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NUC stock has decreased by 7.7% and is now trading at GBX 132.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Nucleus Financial Group?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nucleus Financial Group in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nucleus Financial Group.

How were Nucleus Financial Group's earnings last quarter?

Nucleus Financial Group PLC (LON:NUC) issued its quarterly earnings results on Tuesday, April, 7th. The company reported $7.80 EPS for the quarter, topping the Zacks' consensus estimate of $7.40 by $0.40. View Nucleus Financial Group's earnings history.

How often does Nucleus Financial Group pay dividends? What is the dividend yield for Nucleus Financial Group?

Nucleus Financial Group announced a dividend on Tuesday, September 10th. Investors of record on Thursday, September 19th will be paid a dividend of GBX 1.50 per share on Friday, October 18th. This represents a dividend yield of 0.97%. The ex-dividend date of this dividend is Thursday, September 19th. The official announcement can be seen at this link. View Nucleus Financial Group's dividend history.

What price target have analysts set for NUC?

2 equities research analysts have issued twelve-month price objectives for Nucleus Financial Group's stock. Their forecasts range from GBX 135 to GBX 190. On average, they expect Nucleus Financial Group's stock price to reach GBX 162.50 in the next twelve months. This suggests a possible upside of 22.6% from the stock's current price. View analysts' price targets for Nucleus Financial Group.

Has Nucleus Financial Group been receiving favorable news coverage?

Headlines about NUC stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nucleus Financial Group earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutNucleus Financial Group.

Who are some of Nucleus Financial Group's key competitors?

Who are Nucleus Financial Group's key executives?

Nucleus Financial Group's management team includes the following people:
  • Mr. David Ritchie Ferguson, Founder, CEO & Exec. Director
  • Mr. Stuart James Geard CFA, CFO & Exec. Director
  • Mr. Doug Heron, Chief Operating Officer
  • Mr. Andrew Smith, Chief Technology Officer
  • Ms. Nicola C. Megaw, Chief Legal Officer & Company Sec.

What is Nucleus Financial Group's stock symbol?

Nucleus Financial Group trades on the London Stock Exchange (LON) under the ticker symbol "NUC."

How do I buy shares of Nucleus Financial Group?

Shares of NUC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Nucleus Financial Group's stock price today?

One share of NUC stock can currently be purchased for approximately GBX 132.50.

How big of a company is Nucleus Financial Group?

Nucleus Financial Group has a market capitalization of £101.33 million and generates £51.52 million in revenue each year.

What is Nucleus Financial Group's official website?

The official website for Nucleus Financial Group is www.nucleusfinancial.com.

How can I contact Nucleus Financial Group?

The company can be reached via phone at 44 1312 269 535.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.